151 related articles for article (PubMed ID: 15763329)
1. Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis?
Sugawara Y; Makuuchi M
J Hepatol; 2005 Apr; 42(4):472-5. PubMed ID: 15763329
[No Abstract] [Full Text] [Related]
2. Living donor liver transplantation for hepatitis C virus cirrhosis with a huge portal vein aneurysm.
Miyazaki K; Takatsuki M; Eguchi S; Hidaka M; Tokai H; Hamasaki K; Tajima Y; Kanematsu T
Liver Transpl; 2008 Aug; 14(8):1221-2. PubMed ID: 18668657
[No Abstract] [Full Text] [Related]
3. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
[TBL] [Abstract][Full Text] [Related]
4. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
5. Blood eosinophilia after living donor liver transplantation for hepatitis C virus-related cirrhosis.
Kishi Y; Sugawara Y; Kaneko J; Tamura S; Matsui Y; Makuuchi M
Transplant Proc; 2007 Jun; 39(5):1540-3. PubMed ID: 17580184
[TBL] [Abstract][Full Text] [Related]
6. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
7. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
[TBL] [Abstract][Full Text] [Related]
8. Living donor liver transplantation and hepatitis C.
Gheorghe L; Iacob S; Popescu I
Rom J Gastroenterol; 2004 Dec; 13(4):317-27. PubMed ID: 15624030
[TBL] [Abstract][Full Text] [Related]
9. Rapid normalization of portopulmonary hypertension after living donor liver transplantation.
Sugimachi K; Soejima Y; Morita K; Ueda S; Fukuhara T; Nagata S; Ikegami T; Taketomi A; Maehara Y
Transplant Proc; 2009 Jun; 41(5):1976-8. PubMed ID: 19545772
[TBL] [Abstract][Full Text] [Related]
10. Living donor liver transplantation in patients with chronic hepatitis C: timing is everything.
Shiffman ML
Liver Transpl; 2003 Oct; 9(10):1036-9. PubMed ID: 14526397
[No Abstract] [Full Text] [Related]
11. Reply: Prospective validation of a noninvasive index for predicting liver fibrosis in hepatitis C virus-infected liver transplant recipients.
Cross TJ; Burroughs AK; Harrison PM
Liver Transpl; 2010 Jun; 16(6):789-90; author reply 791-2. PubMed ID: 20517916
[No Abstract] [Full Text] [Related]
12. Role of adult living donor liver transplantation in patients with hepatitis C.
Everson GT; Trotter J
Liver Transpl; 2003 Oct; 9(10 Suppl 2):S64-8. PubMed ID: 14528432
[No Abstract] [Full Text] [Related]
13. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis.
Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K
Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells play divergent roles in shaping the outcome of hepatitis C virus recurrence following liver transplantation.
Golden-Mason L
Liver Transpl; 2009 Apr; 15(4):357-9. PubMed ID: 19326413
[No Abstract] [Full Text] [Related]
15. Liver transplantation: an update 2008.
Said A; Lucey MR
Curr Opin Gastroenterol; 2008 May; 24(3):339-45. PubMed ID: 18408462
[TBL] [Abstract][Full Text] [Related]
16. Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor.
Soejima Y; Shimada M; Taketomi A; Yoshizumi T; Uchiyama H; Ikegami T; Nakamuta M; Maehara Y
Liver Int; 2007 Nov; 27(9):1282-6. PubMed ID: 17919241
[TBL] [Abstract][Full Text] [Related]
17. Use of an interpositional venous graft posterior to the pancreas for LDLT patients with portal vein thrombosis.
Mizuno S; Hori T; Iida T; Yagi S; Usui M; Sakurai H; Isaji S; Shiraki K; Uemoto S
Hepatogastroenterology; 2007 Mar; 54(74):541-4. PubMed ID: 17523318
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C recurrence after living donor and cadaveric liver transplantation].
Coelho JC; Okawa L; Parolin MB; Freitas AC; Matias JE; Matioski AR
Arq Gastroenterol; 2009; 46(1):38-42. PubMed ID: 19466308
[TBL] [Abstract][Full Text] [Related]
19. Liver transplantation: from Child to MELD.
Gallegos-Orozco JF; Vargas HE
Med Clin North Am; 2009 Jul; 93(4):931-50, ix. PubMed ID: 19577123
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Feray C
J Hepatol; 2004 Nov; 41(5):862-3. PubMed ID: 15519662
[No Abstract] [Full Text] [Related]
[Next] [New Search]
